Overview
To evaluate the efficacy and safety of trastuzumab deruxtecan in advanced breast cancer patients.
Eligibility
Inclusion Criteria:
- Aged ≥18 and older
- Breast cancer patients meeting current guideline recommendations and planning to receive trastuzumab deruxtecan
- ECOG 0-1
Exclusion Criteria:
- During pregnancy and lactation